Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-17

FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for olmesartan medoxomil from Lifestar Pharma LLC, granting approval for this antihypertensive generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)